Price Capital Management, Inc. - CELLDEX THERAPEUTICS INC NEW ownership

CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 189 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q2 2015. The put-call ratio across all filers is 1.49 and the average weighting 0.2%.

Quarter-by-quarter ownership
Price Capital Management, Inc. ownership history of CELLDEX THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2015$238,0008,5440.15%
Other shareholders
CELLDEX THERAPEUTICS INC NEW shareholders Q2 2015
NameSharesValueWeighting ↓
Byrne Asset Management LLC 86$2,0000.00%
View complete list of CELLDEX THERAPEUTICS INC NEW shareholders